CTI BioPharma Corp.
CTI BioPharma Corp. (CTIC) Stock Competitors & Peer Comparison
See (CTIC) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CTIC | $9.10 | +0.06% | 1.2B | -16.84 | -$0.54 | N/A |
| NVO | $45.08 | +0.26% | 196.4B | 10.38 | $4.26 | +4.06% |
| VRTX | $441.03 | +1.50% | 110.6B | 25.86 | $16.86 | N/A |
| VRNA | $106.91 | +0.11% | 72.7B | -102.80 | -$1.04 | N/A |
| REGN | $628.89 | -1.56% | 65.4B | 15.50 | $40.95 | +0.57% |
| ARGX | $823.98 | +2.17% | 50B | 35.93 | $22.50 | N/A |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $296.77 | -0.23% | 39.5B | 74.08 | $3.99 | N/A |
| RVMD | $151.70 | +0.09% | 32.9B | -21.76 | -$7.11 | N/A |
| UTHR | $578.03 | +1.69% | 24.6B | 21.39 | $27.06 | N/A |
Stock Comparison
CTIC vs NVO Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, NVO has a market cap of 196.4B. Regarding current trading prices, CTIC is priced at $9.10, while NVO trades at $45.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas NVO's P/E ratio is 10.38. In terms of profitability, CTIC's ROE is +13.18%, compared to NVO's ROE of +0.66%. Regarding short-term risk, CTIC is less volatile compared to NVO. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check NVO's competition here
CTIC vs VRTX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, VRTX has a market cap of 110.6B. Regarding current trading prices, CTIC is priced at $9.10, while VRTX trades at $441.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas VRTX's P/E ratio is 25.86. In terms of profitability, CTIC's ROE is +13.18%, compared to VRTX's ROE of +0.24%. Regarding short-term risk, CTIC is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check VRTX's competition here
CTIC vs VRNA Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, VRNA has a market cap of 72.7B. Regarding current trading prices, CTIC is priced at $9.10, while VRNA trades at $106.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas VRNA's P/E ratio is -102.80. In terms of profitability, CTIC's ROE is +13.18%, compared to VRNA's ROE of -0.13%. Regarding short-term risk, CTIC is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check VRNA's competition here
CTIC vs REGN Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, REGN has a market cap of 65.4B. Regarding current trading prices, CTIC is priced at $9.10, while REGN trades at $628.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas REGN's P/E ratio is 15.50. In terms of profitability, CTIC's ROE is +13.18%, compared to REGN's ROE of +0.14%. Regarding short-term risk, CTIC is less volatile compared to REGN. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check REGN's competition here
CTIC vs ARGX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ARGX has a market cap of 50B. Regarding current trading prices, CTIC is priced at $9.10, while ARGX trades at $823.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ARGX's P/E ratio is 35.93. In terms of profitability, CTIC's ROE is +13.18%, compared to ARGX's ROE of +0.37%. Regarding short-term risk, CTIC is less volatile compared to ARGX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check ARGX's competition here
CTIC vs SGEN Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, CTIC is priced at $9.10, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SGEN's P/E ratio is -57.19. In terms of profitability, CTIC's ROE is +13.18%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, CTIC is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check SGEN's competition here
CTIC vs ALNY Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ALNY has a market cap of 39.5B. Regarding current trading prices, CTIC is priced at $9.10, while ALNY trades at $296.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ALNY's P/E ratio is 74.08. In terms of profitability, CTIC's ROE is +13.18%, compared to ALNY's ROE of +0.98%. Regarding short-term risk, CTIC is less volatile compared to ALNY. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check ALNY's competition here
CTIC vs RVMD Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RVMD has a market cap of 32.9B. Regarding current trading prices, CTIC is priced at $9.10, while RVMD trades at $151.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RVMD's P/E ratio is -21.76. In terms of profitability, CTIC's ROE is +13.18%, compared to RVMD's ROE of -0.83%. Regarding short-term risk, CTIC is less volatile compared to RVMD. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check RVMD's competition here
CTIC vs UTHR Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, UTHR has a market cap of 24.6B. Regarding current trading prices, CTIC is priced at $9.10, while UTHR trades at $578.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas UTHR's P/E ratio is 21.39. In terms of profitability, CTIC's ROE is +13.18%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, CTIC is less volatile compared to UTHR. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check UTHR's competition here
CTIC vs INSM Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, INSM has a market cap of 23.6B. Regarding current trading prices, CTIC is priced at $9.10, while INSM trades at $106.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas INSM's P/E ratio is -18.90. In terms of profitability, CTIC's ROE is +13.18%, compared to INSM's ROE of -1.30%. Regarding short-term risk, CTIC is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check INSM's competition here
CTIC vs BNTX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BNTX has a market cap of 23.3B. Regarding current trading prices, CTIC is priced at $9.10, while BNTX trades at $94.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BNTX's P/E ratio is -15.64. In terms of profitability, CTIC's ROE is +13.18%, compared to BNTX's ROE of -0.07%. Regarding short-term risk, CTIC is less volatile compared to BNTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check BNTX's competition here
CTIC vs RPRX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RPRX has a market cap of 23.2B. Regarding current trading prices, CTIC is priced at $9.10, while RPRX trades at $54.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RPRX's P/E ratio is 28.35. In terms of profitability, CTIC's ROE is +13.18%, compared to RPRX's ROE of +0.13%. Regarding short-term risk, CTIC is less volatile compared to RPRX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check RPRX's competition here
CTIC vs ROIV Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ROIV has a market cap of 21.3B. Regarding current trading prices, CTIC is priced at $9.10, while ROIV trades at $29.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ROIV's P/E ratio is -54.94. In terms of profitability, CTIC's ROE is +13.18%, compared to ROIV's ROE of -0.07%. Regarding short-term risk, CTIC is less volatile compared to ROIV. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check ROIV's competition here
CTIC vs BGNE Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, CTIC is priced at $9.10, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BGNE's P/E ratio is -22.55. In terms of profitability, CTIC's ROE is +13.18%, compared to BGNE's ROE of +0.12%. Regarding short-term risk, CTIC is less volatile compared to BGNE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check BGNE's competition here
CTIC vs INCY Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, INCY has a market cap of 19.4B. Regarding current trading prices, CTIC is priced at $9.10, while INCY trades at $98.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas INCY's P/E ratio is 13.71. In terms of profitability, CTIC's ROE is +13.18%, compared to INCY's ROE of +0.29%. Regarding short-term risk, CTIC is less volatile compared to INCY. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check INCY's competition here
CTIC vs DNA-WT Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, CTIC is priced at $9.10, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, CTIC's ROE is +13.18%, compared to DNA-WT's ROE of -0.57%. Regarding short-term risk, CTIC is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check DNA-WT's competition here
CTIC vs MRNA Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MRNA has a market cap of 18.7B. Regarding current trading prices, CTIC is priced at $9.10, while MRNA trades at $48.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MRNA's P/E ratio is -5.78. In terms of profitability, CTIC's ROE is +13.18%, compared to MRNA's ROE of -0.37%. Regarding short-term risk, CTIC is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check MRNA's competition here
CTIC vs GMAB Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, GMAB has a market cap of 16.5B. Regarding current trading prices, CTIC is priced at $9.10, while GMAB trades at $26.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas GMAB's P/E ratio is 20.53. In terms of profitability, CTIC's ROE is +13.18%, compared to GMAB's ROE of +0.21%. Regarding short-term risk, CTIC is less volatile compared to GMAB. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check GMAB's competition here
CTIC vs NBIX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, NBIX has a market cap of 15.7B. Regarding current trading prices, CTIC is priced at $9.10, while NBIX trades at $156.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas NBIX's P/E ratio is 23.98. In terms of profitability, CTIC's ROE is +13.18%, compared to NBIX's ROE of +0.22%. Regarding short-term risk, CTIC is less volatile compared to NBIX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check NBIX's competition here
CTIC vs JAZZ Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, JAZZ has a market cap of 14.9B. Regarding current trading prices, CTIC is priced at $9.10, while JAZZ trades at $239.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas JAZZ's P/E ratio is 1978.25. In terms of profitability, CTIC's ROE is +13.18%, compared to JAZZ's ROE of +0.01%. Regarding short-term risk, CTIC is less volatile compared to JAZZ. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check JAZZ's competition here
CTIC vs ASND Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ASND has a market cap of 14.8B. Regarding current trading prices, CTIC is priced at $9.10, while ASND trades at $237.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ASND's P/E ratio is 27.26. In terms of profitability, CTIC's ROE is +13.18%, compared to ASND's ROE of -56.42%. Regarding short-term risk, CTIC is less volatile compared to ASND. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check ASND's competition here
CTIC vs BBIO Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BBIO has a market cap of 13.3B. Regarding current trading prices, CTIC is priced at $9.10, while BBIO trades at $65.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BBIO's P/E ratio is -18.11. In terms of profitability, CTIC's ROE is +13.18%, compared to BBIO's ROE of +0.36%. Regarding short-term risk, CTIC is less volatile compared to BBIO. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check BBIO's competition here
CTIC vs SMMT Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SMMT has a market cap of 13.2B. Regarding current trading prices, CTIC is priced at $9.10, while SMMT trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SMMT's P/E ratio is -10.69. In terms of profitability, CTIC's ROE is +13.18%, compared to SMMT's ROE of -3.41%. Regarding short-term risk, CTIC is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check SMMT's competition here
CTIC vs KRTX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, CTIC is priced at $9.10, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas KRTX's P/E ratio is -28.09. In terms of profitability, CTIC's ROE is +13.18%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, CTIC is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check KRTX's competition here
CTIC vs EXEL Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, EXEL has a market cap of 12.6B. Regarding current trading prices, CTIC is priced at $9.10, while EXEL trades at $50.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas EXEL's P/E ratio is 16.57. In terms of profitability, CTIC's ROE is +13.18%, compared to EXEL's ROE of +0.40%. Regarding short-term risk, CTIC is less volatile compared to EXEL. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check EXEL's competition here
CTIC vs IONS Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, IONS has a market cap of 12.6B. Regarding current trading prices, CTIC is priced at $9.10, while IONS trades at $76.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas IONS's P/E ratio is -37.85. In terms of profitability, CTIC's ROE is +13.18%, compared to IONS's ROE of -0.59%. Regarding short-term risk, CTIC is less volatile compared to IONS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check IONS's competition here
CTIC vs MDGL Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MDGL has a market cap of 12.1B. Regarding current trading prices, CTIC is priced at $9.10, while MDGL trades at $528.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MDGL's P/E ratio is -38.81. In terms of profitability, CTIC's ROE is +13.18%, compared to MDGL's ROE of -0.50%. Regarding short-term risk, CTIC is less volatile compared to MDGL. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check MDGL's competition here
CTIC vs AXSM Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, AXSM has a market cap of 12.1B. Regarding current trading prices, CTIC is priced at $9.10, while AXSM trades at $234.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas AXSM's P/E ratio is -62.79. In terms of profitability, CTIC's ROE is +13.18%, compared to AXSM's ROE of -2.60%. Regarding short-term risk, CTIC is less volatile compared to AXSM. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check AXSM's competition here
CTIC vs RNAM Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RNAM has a market cap of 11.3B. Regarding current trading prices, CTIC is priced at $9.10, while RNAM trades at $72.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RNAM's P/E ratio is -17.39. In terms of profitability, CTIC's ROE is +13.18%, compared to RNAM's ROE of -0.45%. Regarding short-term risk, CTIC is more volatile compared to RNAM. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check RNAM's competition here
CTIC vs ARWR Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ARWR has a market cap of 11.1B. Regarding current trading prices, CTIC is priced at $9.10, while ARWR trades at $79.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ARWR's P/E ratio is -34.66. In terms of profitability, CTIC's ROE is +13.18%, compared to ARWR's ROE of -0.55%. Regarding short-term risk, CTIC is less volatile compared to ARWR. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check ARWR's competition here
CTIC vs BMRN Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BMRN has a market cap of 10.2B. Regarding current trading prices, CTIC is priced at $9.10, while BMRN trades at $52.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BMRN's P/E ratio is 38.04. In terms of profitability, CTIC's ROE is +13.18%, compared to BMRN's ROE of +0.04%. Regarding short-term risk, CTIC is less volatile compared to BMRN. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check BMRN's competition here
CTIC vs RXDX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, CTIC is priced at $9.10, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RXDX's P/E ratio is -56.47. In terms of profitability, CTIC's ROE is +13.18%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, CTIC is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check RXDX's competition here
CTIC vs CYTK Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CYTK has a market cap of 9.5B. Regarding current trading prices, CTIC is priced at $9.10, while CYTK trades at $77.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CYTK's P/E ratio is -11.14. In terms of profitability, CTIC's ROE is +13.18%, compared to CYTK's ROE of +1.40%. Regarding short-term risk, CTIC is less volatile compared to CYTK. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check CYTK's competition here
CTIC vs KRYS Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, KRYS has a market cap of 8.9B. Regarding current trading prices, CTIC is priced at $9.10, while KRYS trades at $305.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas KRYS's P/E ratio is 40.47. In terms of profitability, CTIC's ROE is +13.18%, compared to KRYS's ROE of +0.19%. Regarding short-term risk, CTIC is less volatile compared to KRYS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check KRYS's competition here
CTIC vs IMGN Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, CTIC is priced at $9.10, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas IMGN's P/E ratio is -111.55. In terms of profitability, CTIC's ROE is +13.18%, compared to IMGN's ROE of -0.93%. Regarding short-term risk, CTIC is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check IMGN's competition here
CTIC vs BPMC Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, CTIC is priced at $9.10, while BPMC trades at $129.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BPMC's P/E ratio is -51.58. In terms of profitability, CTIC's ROE is +13.18%, compared to BPMC's ROE of -0.15%. Regarding short-term risk, CTIC is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check BPMC's competition here
CTIC vs IBRX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, IBRX has a market cap of 8.3B. Regarding current trading prices, CTIC is priced at $9.10, while IBRX trades at $7.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas IBRX's P/E ratio is -9.31. In terms of profitability, CTIC's ROE is +13.18%, compared to IBRX's ROE of +1.39%. Regarding short-term risk, CTIC is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check IBRX's competition here
CTIC vs ABVX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ABVX has a market cap of 8.3B. Regarding current trading prices, CTIC is priced at $9.10, while ABVX trades at $129.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ABVX's P/E ratio is -23.55. In terms of profitability, CTIC's ROE is +13.18%, compared to ABVX's ROE of -1.65%. Regarding short-term risk, CTIC is less volatile compared to ABVX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check ABVX's competition here
CTIC vs CERE Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, CTIC is priced at $9.10, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CERE's P/E ratio is -16.47. In terms of profitability, CTIC's ROE is +13.18%, compared to CERE's ROE of -0.72%. Regarding short-term risk, CTIC is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check CERE's competition here
CTIC vs HALO Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, HALO has a market cap of 8.2B. Regarding current trading prices, CTIC is priced at $9.10, while HALO trades at $69.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas HALO's P/E ratio is 24.11. In terms of profitability, CTIC's ROE is +13.18%, compared to HALO's ROE of +1.26%. Regarding short-term risk, CTIC is less volatile compared to HALO. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check HALO's competition here
CTIC vs NUVL Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, NUVL has a market cap of 7.7B. Regarding current trading prices, CTIC is priced at $9.10, while NUVL trades at $107.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas NUVL's P/E ratio is -17.32. In terms of profitability, CTIC's ROE is +13.18%, compared to NUVL's ROE of -0.43%. Regarding short-term risk, CTIC is less volatile compared to NUVL. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check NUVL's competition here
CTIC vs TECH Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, TECH has a market cap of 7.5B. Regarding current trading prices, CTIC is priced at $9.10, while TECH trades at $47.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas TECH's P/E ratio is 68.53. In terms of profitability, CTIC's ROE is +13.18%, compared to TECH's ROE of +0.05%. Regarding short-term risk, CTIC is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check TECH's competition here
CTIC vs MTSR Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MTSR has a market cap of 7.4B. Regarding current trading prices, CTIC is priced at $9.10, while MTSR trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MTSR's P/E ratio is -23.58. In terms of profitability, CTIC's ROE is +13.18%, compared to MTSR's ROE of -0.80%. Regarding short-term risk, CTIC is less volatile compared to MTSR. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check MTSR's competition here
CTIC vs PRAX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, PRAX has a market cap of 7.4B. Regarding current trading prices, CTIC is priced at $9.10, while PRAX trades at $354.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas PRAX's P/E ratio is -26.16. In terms of profitability, CTIC's ROE is +13.18%, compared to PRAX's ROE of -0.43%. Regarding short-term risk, CTIC is less volatile compared to PRAX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check PRAX's competition here
CTIC vs PCVX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, PCVX has a market cap of 7.2B. Regarding current trading prices, CTIC is priced at $9.10, while PCVX trades at $50.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas PCVX's P/E ratio is -7.27. In terms of profitability, CTIC's ROE is +13.18%, compared to PCVX's ROE of -0.33%. Regarding short-term risk, CTIC is less volatile compared to PCVX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check PCVX's competition here
CTIC vs IMVT Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, IMVT has a market cap of 6.9B. Regarding current trading prices, CTIC is priced at $9.10, while IMVT trades at $33.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas IMVT's P/E ratio is -12.21. In terms of profitability, CTIC's ROE is +13.18%, compared to IMVT's ROE of -0.68%. Regarding short-term risk, CTIC is less volatile compared to IMVT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check IMVT's competition here
CTIC vs MRUS Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MRUS has a market cap of 6.8B. Regarding current trading prices, CTIC is priced at $9.10, while MRUS trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MRUS's P/E ratio is -17.05. In terms of profitability, CTIC's ROE is +13.18%, compared to MRUS's ROE of -0.51%. Regarding short-term risk, CTIC is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check MRUS's competition here
CTIC vs ACLX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ACLX has a market cap of 6.7B. Regarding current trading prices, CTIC is priced at $9.10, while ACLX trades at $115.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ACLX's P/E ratio is -28.27. In terms of profitability, CTIC's ROE is +13.18%, compared to ACLX's ROE of -0.55%. Regarding short-term risk, CTIC is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check ACLX's competition here
CTIC vs KYMR Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, KYMR has a market cap of 6.6B. Regarding current trading prices, CTIC is priced at $9.10, while KYMR trades at $81.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas KYMR's P/E ratio is -22.56. In terms of profitability, CTIC's ROE is +13.18%, compared to KYMR's ROE of -0.25%. Regarding short-term risk, CTIC is less volatile compared to KYMR. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check KYMR's competition here
CTIC vs RETA Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, CTIC is priced at $9.10, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RETA's P/E ratio is -66.29. In terms of profitability, CTIC's ROE is +13.18%, compared to RETA's ROE of +0.47%. Regarding short-term risk, CTIC is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check RETA's competition here
CTIC vs CELC Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CELC has a market cap of 6.5B. Regarding current trading prices, CTIC is priced at $9.10, while CELC trades at $132.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CELC's P/E ratio is -34.51. In terms of profitability, CTIC's ROE is +13.18%, compared to CELC's ROE of -2.45%. Regarding short-term risk, CTIC is less volatile compared to CELC. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check CELC's competition here
CTIC vs CORT Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CORT has a market cap of 6.5B. Regarding current trading prices, CTIC is priced at $9.10, while CORT trades at $64.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CORT's P/E ratio is 172.46. In terms of profitability, CTIC's ROE is +13.18%, compared to CORT's ROE of +0.08%. Regarding short-term risk, CTIC is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check CORT's competition here
CTIC vs PTGX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, PTGX has a market cap of 6.4B. Regarding current trading prices, CTIC is priced at $9.10, while PTGX trades at $99.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas PTGX's P/E ratio is -55.24. In terms of profitability, CTIC's ROE is +13.18%, compared to PTGX's ROE of -0.18%. Regarding short-term risk, CTIC is less volatile compared to PTGX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check PTGX's competition here
CTIC vs ALKS Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ALKS has a market cap of 6.2B. Regarding current trading prices, CTIC is priced at $9.10, while ALKS trades at $37.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ALKS's P/E ratio is 41.50. In terms of profitability, CTIC's ROE is +13.18%, compared to ALKS's ROE of +0.09%. Regarding short-term risk, CTIC is less volatile compared to ALKS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check ALKS's competition here
CTIC vs SRRK Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SRRK has a market cap of 6.2B. Regarding current trading prices, CTIC is priced at $9.10, while SRRK trades at $50.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SRRK's P/E ratio is -14.93. In terms of profitability, CTIC's ROE is +13.18%, compared to SRRK's ROE of -1.64%. Regarding short-term risk, CTIC is less volatile compared to SRRK. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check SRRK's competition here
CTIC vs RYTM Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RYTM has a market cap of 6.2B. Regarding current trading prices, CTIC is priced at $9.10, while RYTM trades at $91.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RYTM's P/E ratio is -28.70. In terms of profitability, CTIC's ROE is +13.18%, compared to RYTM's ROE of -2.03%. Regarding short-term risk, CTIC is less volatile compared to RYTM. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check RYTM's competition here
CTIC vs CNTA Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CNTA has a market cap of 6.2B. Regarding current trading prices, CTIC is priced at $9.10, while CNTA trades at $39.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CNTA's P/E ratio is -22.35. In terms of profitability, CTIC's ROE is +13.18%, compared to CNTA's ROE of -0.60%. Regarding short-term risk, CTIC is less volatile compared to CNTA. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check CNTA's competition here
CTIC vs TGTX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, TGTX has a market cap of 6.1B. Regarding current trading prices, CTIC is priced at $9.10, while TGTX trades at $40.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas TGTX's P/E ratio is 13.89. In terms of profitability, CTIC's ROE is +13.18%, compared to TGTX's ROE of +0.87%. Regarding short-term risk, CTIC is less volatile compared to TGTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check TGTX's competition here
CTIC vs COGT Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, COGT has a market cap of 5.8B. Regarding current trading prices, CTIC is priced at $9.10, while COGT trades at $33.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas COGT's P/E ratio is -15.64. In terms of profitability, CTIC's ROE is +13.18%, compared to COGT's ROE of -0.83%. Regarding short-term risk, CTIC is less volatile compared to COGT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check COGT's competition here
CTIC vs BLTE Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BLTE has a market cap of 5.7B. Regarding current trading prices, CTIC is priced at $9.10, while BLTE trades at $141.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BLTE's P/E ratio is -55.91. In terms of profitability, CTIC's ROE is +13.18%, compared to BLTE's ROE of -0.27%. Regarding short-term risk, CTIC is less volatile compared to BLTE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check BLTE's competition here
CTIC vs CDTX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CDTX has a market cap of 5.6B. Regarding current trading prices, CTIC is priced at $9.10, while CDTX trades at $221.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CDTX's P/E ratio is -19.77. In terms of profitability, CTIC's ROE is +13.18%, compared to CDTX's ROE of -0.60%. Regarding short-term risk, CTIC is more volatile compared to CDTX. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check CDTX's competition here
CTIC vs PTCT Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, PTCT has a market cap of 5.6B. Regarding current trading prices, CTIC is priced at $9.10, while PTCT trades at $70.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas PTCT's P/E ratio is -26.63. In terms of profitability, CTIC's ROE is +13.18%, compared to PTCT's ROE of +1.00%. Regarding short-term risk, CTIC is less volatile compared to PTCT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check PTCT's competition here
CTIC vs ABCM Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, CTIC is priced at $9.10, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, CTIC's ROE is +13.18%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, CTIC is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check ABCM's competition here
CTIC vs ISEE Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, CTIC is priced at $9.10, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ISEE's P/E ratio is -22.44. In terms of profitability, CTIC's ROE is +13.18%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, CTIC is less volatile compared to ISEE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check ISEE's competition here
CTIC vs LEGN Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, LEGN has a market cap of 5.5B. Regarding current trading prices, CTIC is priced at $9.10, while LEGN trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas LEGN's P/E ratio is -21.40. In terms of profitability, CTIC's ROE is +13.18%, compared to LEGN's ROE of -0.25%. Regarding short-term risk, CTIC is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check LEGN's competition here
CTIC vs CGON Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CGON has a market cap of 5.5B. Regarding current trading prices, CTIC is priced at $9.10, while CGON trades at $60.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CGON's P/E ratio is -26.41. In terms of profitability, CTIC's ROE is +13.18%, compared to CGON's ROE of -0.23%. Regarding short-term risk, CTIC is less volatile compared to CGON. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check CGON's competition here
CTIC vs LQDA Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, LQDA has a market cap of 5.3B. Regarding current trading prices, CTIC is priced at $9.10, while LQDA trades at $62.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas LQDA's P/E ratio is 353.50. In terms of profitability, CTIC's ROE is +13.18%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, CTIC is less volatile compared to LQDA. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check LQDA's competition here
CTIC vs APLS Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, APLS has a market cap of 5.3B. Regarding current trading prices, CTIC is priced at $9.10, while APLS trades at $41.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas APLS's P/E ratio is 38.35. In terms of profitability, CTIC's ROE is +13.18%, compared to APLS's ROE of +0.40%. Regarding short-term risk, CTIC is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check APLS's competition here
CTIC vs FBIOX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, FBIOX has a market cap of 5.2B. Regarding current trading prices, CTIC is priced at $9.10, while FBIOX trades at $25.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas FBIOX's P/E ratio is N/A. In terms of profitability, CTIC's ROE is +13.18%, compared to FBIOX's ROE of +0.00%. Regarding short-term risk, CTIC is more volatile compared to FBIOX. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check FBIOX's competition here
CTIC vs APGE Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, APGE has a market cap of 5.1B. Regarding current trading prices, CTIC is priced at $9.10, while APGE trades at $79.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas APGE's P/E ratio is -19.12. In terms of profitability, CTIC's ROE is +13.18%, compared to APGE's ROE of -0.33%. Regarding short-term risk, CTIC is less volatile compared to APGE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check APGE's competition here
CTIC vs CRSP Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CRSP has a market cap of 5B. Regarding current trading prices, CTIC is priced at $9.10, while CRSP trades at $53.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CRSP's P/E ratio is -8.36. In terms of profitability, CTIC's ROE is +13.18%, compared to CRSP's ROE of -0.31%. Regarding short-term risk, CTIC is less volatile compared to CRSP. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check CRSP's competition here
CTIC vs MIRM Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MIRM has a market cap of 5B. Regarding current trading prices, CTIC is priced at $9.10, while MIRM trades at $98.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MIRM's P/E ratio is -7.27. In terms of profitability, CTIC's ROE is +13.18%, compared to MIRM's ROE of -2.89%. Regarding short-term risk, CTIC is less volatile compared to MIRM. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check MIRM's competition here
CTIC vs TERN Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, TERN has a market cap of 4.8B. Regarding current trading prices, CTIC is priced at $9.10, while TERN trades at $52.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas TERN's P/E ratio is -51.41. In terms of profitability, CTIC's ROE is +13.18%, compared to TERN's ROE of -0.20%. Regarding short-term risk, CTIC is more volatile compared to TERN. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check TERN's competition here
CTIC vs LGND Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, LGND has a market cap of 4.7B. Regarding current trading prices, CTIC is priced at $9.10, while LGND trades at $236.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas LGND's P/E ratio is 30.72. In terms of profitability, CTIC's ROE is +13.18%, compared to LGND's ROE of +0.16%. Regarding short-term risk, CTIC is less volatile compared to LGND. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check LGND's competition here
CTIC vs FOLD Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, FOLD has a market cap of 4.5B. Regarding current trading prices, CTIC is priced at $9.10, while FOLD trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas FOLD's P/E ratio is -161.00. In terms of profitability, CTIC's ROE is +13.18%, compared to FOLD's ROE of -0.12%. Regarding short-term risk, CTIC is more volatile compared to FOLD. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check FOLD's competition here
CTIC vs AKRO Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, AKRO has a market cap of 4.5B. Regarding current trading prices, CTIC is priced at $9.10, while AKRO trades at $54.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas AKRO's P/E ratio is -14.57. In terms of profitability, CTIC's ROE is +13.18%, compared to AKRO's ROE of -0.31%. Regarding short-term risk, CTIC is less volatile compared to AKRO. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check AKRO's competition here
CTIC vs ALPN Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, CTIC is priced at $9.10, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ALPN's P/E ratio is -101.52. In terms of profitability, CTIC's ROE is +13.18%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, CTIC is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check ALPN's competition here
CTIC vs SYRE Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SYRE has a market cap of 4.4B. Regarding current trading prices, CTIC is priced at $9.10, while SYRE trades at $73.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SYRE's P/E ratio is -34.72. In terms of profitability, CTIC's ROE is +13.18%, compared to SYRE's ROE of -0.31%. Regarding short-term risk, CTIC is less volatile compared to SYRE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check SYRE's competition here
CTIC vs CAI Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CAI has a market cap of 4.4B. Regarding current trading prices, CTIC is priced at $9.10, while CAI trades at $15.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CAI's P/E ratio is -5.62. In terms of profitability, CTIC's ROE is +13.18%, compared to CAI's ROE of +0.06%. Regarding short-term risk, CTIC is less volatile compared to CAI. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check CAI's competition here
CTIC vs MANE Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MANE has a market cap of 4.3B. Regarding current trading prices, CTIC is priced at $9.10, while MANE trades at $99.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MANE's P/E ratio is -38.68. In terms of profitability, CTIC's ROE is +13.18%, compared to MANE's ROE of -0.95%. Regarding short-term risk, CTIC is less volatile compared to MANE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check MANE's competition here
CTIC vs XENE Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, XENE has a market cap of 4.3B. Regarding current trading prices, CTIC is priced at $9.10, while XENE trades at $53.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas XENE's P/E ratio is -11.49. In terms of profitability, CTIC's ROE is +13.18%, compared to XENE's ROE of -0.49%. Regarding short-term risk, CTIC is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check XENE's competition here
CTIC vs OPT Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, CTIC is priced at $9.10, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas OPT's P/E ratio is -1.52. In terms of profitability, CTIC's ROE is +13.18%, compared to OPT's ROE of +0.88%. Regarding short-term risk, CTIC is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check OPT's competition here
CTIC vs NAMS Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, NAMS has a market cap of 4.2B. Regarding current trading prices, CTIC is priced at $9.10, while NAMS trades at $36.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas NAMS's P/E ratio is -20.29. In terms of profitability, CTIC's ROE is +13.18%, compared to NAMS's ROE of -0.30%. Regarding short-term risk, CTIC is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check NAMS's competition here
CTIC vs TVTX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, TVTX has a market cap of 4.1B. Regarding current trading prices, CTIC is priced at $9.10, while TVTX trades at $46.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas TVTX's P/E ratio is -88.58. In terms of profitability, CTIC's ROE is +13.18%, compared to TVTX's ROE of -0.27%. Regarding short-term risk, CTIC is less volatile compared to TVTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check TVTX's competition here
CTIC vs MRTX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, CTIC is priced at $9.10, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MRTX's P/E ratio is -4.82. In terms of profitability, CTIC's ROE is +13.18%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, CTIC is less volatile compared to MRTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check MRTX's competition here
CTIC vs KNSA Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, KNSA has a market cap of 4B. Regarding current trading prices, CTIC is priced at $9.10, while KNSA trades at $52.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas KNSA's P/E ratio is 58.03. In terms of profitability, CTIC's ROE is +13.18%, compared to KNSA's ROE of +0.13%. Regarding short-term risk, CTIC is less volatile compared to KNSA. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check KNSA's competition here
CTIC vs CRNX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CRNX has a market cap of 3.9B. Regarding current trading prices, CTIC is priced at $9.10, while CRNX trades at $36.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CRNX's P/E ratio is -7.16. In terms of profitability, CTIC's ROE is +13.18%, compared to CRNX's ROE of -0.44%. Regarding short-term risk, CTIC is less volatile compared to CRNX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check CRNX's competition here
CTIC vs CPRX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CPRX has a market cap of 3.8B. Regarding current trading prices, CTIC is priced at $9.10, while CPRX trades at $31.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CPRX's P/E ratio is 18.11. In terms of profitability, CTIC's ROE is +13.18%, compared to CPRX's ROE of +0.24%. Regarding short-term risk, CTIC is less volatile compared to CPRX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check CPRX's competition here
CTIC vs RYZB Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, CTIC is priced at $9.10, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RYZB's P/E ratio is -57.86. In terms of profitability, CTIC's ROE is +13.18%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, CTIC is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check RYZB's competition here
CTIC vs CBAY Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, CTIC is priced at $9.10, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CBAY's P/E ratio is -32.81. In terms of profitability, CTIC's ROE is +13.18%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, CTIC is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check CBAY's competition here
CTIC vs ACAD Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ACAD has a market cap of 3.6B. Regarding current trading prices, CTIC is priced at $9.10, while ACAD trades at $21.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ACAD's P/E ratio is 9.62. In terms of profitability, CTIC's ROE is +13.18%, compared to ACAD's ROE of +0.36%. Regarding short-term risk, CTIC is less volatile compared to ACAD. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check ACAD's competition here
CTIC vs DNTH Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, DNTH has a market cap of 3.6B. Regarding current trading prices, CTIC is priced at $9.10, while DNTH trades at $88.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas DNTH's P/E ratio is -20.52. In terms of profitability, CTIC's ROE is +13.18%, compared to DNTH's ROE of -0.02%. Regarding short-term risk, CTIC is less volatile compared to DNTH. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check DNTH's competition here
CTIC vs EWTX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, EWTX has a market cap of 3.6B. Regarding current trading prices, CTIC is priced at $9.10, while EWTX trades at $33.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas EWTX's P/E ratio is -20.22. In terms of profitability, CTIC's ROE is +13.18%, compared to EWTX's ROE of -0.33%. Regarding short-term risk, CTIC is less volatile compared to EWTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check EWTX's competition here
CTIC vs ERAS Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ERAS has a market cap of 3.6B. Regarding current trading prices, CTIC is priced at $9.10, while ERAS trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ERAS's P/E ratio is -12.37. In terms of profitability, CTIC's ROE is +13.18%, compared to ERAS's ROE of -0.77%. Regarding short-term risk, CTIC is less volatile compared to ERAS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check ERAS's competition here
CTIC vs VKTX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, VKTX has a market cap of 3.6B. Regarding current trading prices, CTIC is priced at $9.10, while VKTX trades at $31.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas VKTX's P/E ratio is -7.42. In terms of profitability, CTIC's ROE is +13.18%, compared to VKTX's ROE of -0.71%. Regarding short-term risk, CTIC is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check VKTX's competition here
CTIC vs SWTX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, CTIC is priced at $9.10, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SWTX's P/E ratio is -13.78. In terms of profitability, CTIC's ROE is +13.18%, compared to SWTX's ROE of -0.36%. Regarding short-term risk, CTIC is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.Check SWTX's competition here
CTIC vs VCYT Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, VCYT has a market cap of 3.5B. Regarding current trading prices, CTIC is priced at $9.10, while VCYT trades at $43.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas VCYT's P/E ratio is 40.94. In terms of profitability, CTIC's ROE is +13.18%, compared to VCYT's ROE of +0.07%. Regarding short-term risk, CTIC is less volatile compared to VCYT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check VCYT's competition here
CTIC vs TLX Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, TLX has a market cap of 3.2B. Regarding current trading prices, CTIC is priced at $9.10, while TLX trades at $9.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas TLX's P/E ratio is -478.50. In terms of profitability, CTIC's ROE is +13.18%, compared to TLX's ROE of -0.02%. Regarding short-term risk, CTIC is less volatile compared to TLX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check TLX's competition here
CTIC vs DNLI Comparison May 2026
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, DNLI has a market cap of 3.1B. Regarding current trading prices, CTIC is priced at $9.10, while DNLI trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas DNLI's P/E ratio is -6.73. In terms of profitability, CTIC's ROE is +13.18%, compared to DNLI's ROE of -0.52%. Regarding short-term risk, CTIC is less volatile compared to DNLI. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.Check DNLI's competition here